{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:19:46Z","timestamp":1790893186138,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:00:00Z","timestamp":1436918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12035-015-9303-2","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:58:44Z","timestamp":1436835524000},"page":"3927-3938","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats"],"prefix":"10.1007","volume":"53","author":[{"given":"Lamiaa A.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatallah A.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HebatAllah A.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,15]]},"reference":[{"key":"9303_CR1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","volume":"18","author":"AC Ludolph","year":"1991","unstructured":"Ludolph AC, He F, Spencer PS et al (1991) 3-Nitropropionic acid exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492\u2013498","journal-title":"Can J Neurol Sci"},{"key":"9303_CR2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"E Brouillet","year":"2005","unstructured":"Brouillet E, Jacquard C, Bizat N et al (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J Neurochem 95:1521\u20131540","journal-title":"J Neurochem"},{"key":"9303_CR3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2174\/1389450111007011218","volume":"11","author":"TR Rosenstock","year":"2010","unstructured":"Rosenstock TR, Duarte AI, Rego AC (2010) Mitochondrial-associated metabolic changes and neurodegeneration in Huntington\u2019s disease - from clinical features to the bench. Curr Drug Targets 11:1218\u20131236","journal-title":"Curr Drug Targets"},{"key":"9303_CR4","doi-asserted-by":"crossref","first-page":"9.48.1","DOI":"10.1002\/0471142301.ns0948s67","volume":"67","author":"E Brouillet","year":"2014","unstructured":"Brouillet E (2014) The 3-NP model of striatal neurodegeneration. Curr Protoc Neurosci 67:9.48.1\u20139.48.14","journal-title":"Curr Protoc Neurosci"},{"key":"9303_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-0102(97)00045-X","volume":"29","author":"CV Borlongan","year":"1997","unstructured":"Borlongan CV, Nishino H, Sanberg PR (1997) Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation. Neurosci Res 29:185\u2013189","journal-title":"Neurosci Res"},{"issue":"6","key":"9303_CR6","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/j.1471-4159.2010.06876.x","volume":"114","author":"J Ding","year":"2010","unstructured":"Ding J, Li QY, Wang X et al (2010) Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice. J Neurochem 114(6):1619\u20131629","journal-title":"J Neurochem"},{"key":"9303_CR7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","volume":"4","author":"BK Mueller","year":"2005","unstructured":"Mueller BK, Mack H, Teusch N (2005) Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 4:387\u2013398","journal-title":"Nat Rev Drug Discov"},{"key":"9303_CR8","doi-asserted-by":"crossref","unstructured":"Labandeira-Garcia JL, Rodr\u00edguez-Perez AI, Villar-Cheda B et al. (2014) Rho Kinase and Dopaminergic Degeneration: a promising therapeutic target for parkinson\u2019s disease. Neuroscientist [Epub ahead of print]","DOI":"10.1177\/1073858414554954"},{"key":"9303_CR9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0896-6273(03)00697-4","volume":"40","author":"SK Pollitt","year":"2003","unstructured":"Pollitt SK, Pallos J, Shao J et al (2003) A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron 40:685\u2013694","journal-title":"Neuron"},{"key":"9303_CR10","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.ATV.0000142813.33538.82","volume":"24","author":"S Wolfrum","year":"2004","unstructured":"Wolfrum S, Dendorfer A, Rikitake Y et al (2004) Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase\/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24:1842\u20131847","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"9303_CR11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1227\/01.NEU.0000327574.32000.9A","volume":"63","author":"I Omeis","year":"2008","unstructured":"Omeis I, Jayson NA, Murali R et al (2008) Treatment of cerebral vasospasm with biocompatible controlled release systems for intracranial drug delivery. Neurosurgery 63(6):1011\u20131019","journal-title":"Neurosurgery"},{"issue":"2","key":"9303_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ceb.2008.01.002","volume":"20","author":"MF Olson","year":"2008","unstructured":"Olson MF (2008) Applications for ROCK kinase inhibition. Curr Opin Cell Biol 20(2):242\u2013248","journal-title":"Curr Opin Cell Biol"},{"key":"9303_CR13","first-page":"430791","volume":"2013","author":"R Guo","year":"2013","unstructured":"Guo R, Liu B, Zhou S et al (2013) The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress. Biomed Res Int 2013:430791","journal-title":"Biomed Res Int"},{"issue":"10","key":"9303_CR14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2176\/nmc.51.679","volume":"51","author":"J Zhao","year":"2011","unstructured":"Zhao J, Zhou D, Guo J et al (2011) Fasudil Aneurysmal Subarachnoid Hemorrhage Study Group. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo) 51(10):679\u2013683","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"9303_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10571-008-9308-8","volume":"29","author":"Q Li","year":"2009","unstructured":"Li Q, Huang XJ, He W et al (2009) Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats. Cell Mol Neurobiol 29:169\u2013180","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"9303_CR16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","volume":"88","author":"PJ Most Van der","year":"2009","unstructured":"Van der Most PJ, Dolga AM, Nijholt IM et al (2009) Statins: mechanisms of neuroprotection. Prog Neurobiol 88(1):64\u201375","journal-title":"Prog Neurobiol"},{"issue":"12","key":"9303_CR17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","volume":"97","author":"Y Rikitake","year":"2005","unstructured":"Rikitake Y, Liao JK (2005) Rho GTPases, statins, and nitric oxide. Circ Res 97(12):1232\u20131235","journal-title":"Circ Res"},{"issue":"1","key":"9303_CR18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4236\/jbbs.2013.31010","volume":"3","author":"D Yang","year":"2013","unstructured":"Yang D, Knight RA, Han Y et al (2013) Statins protect the blood brain barrier acutely after experimental intracerebral hemorrhage. J Behav Brain Sci 3(1):100\u2013106","journal-title":"J Behav Brain Sci"},{"key":"9303_CR19","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG et al (1993) Neurochemical and Histologic characterization of Striatal excitotoxin lesions produced by mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"issue":"2","key":"9303_CR20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/FJC.0b013e31802df112","volume":"49","author":"BH Jiang","year":"2007","unstructured":"Jiang BH, Tawara S, Abe K et al (2007) Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol 49(2):85\u201389","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"9303_CR21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11033-012-2120-z","volume":"40","author":"H Zhao","year":"2013","unstructured":"Zhao H, Ji Z, Tang D et al (2013) Role of autophagy in early brain injury after subarachnoid hemorrhage in rats. Mol Biol Rep 40(2):819\u2013827","journal-title":"Mol Biol Rep"},{"key":"9303_CR22","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1523\/JNEUROSCI.22-11-04478.2002","volume":"22","author":"V Mittoux","year":"2002","unstructured":"Mittoux V, Ouary S, Monville C et al (2002) Corticostriatopallidal neuroprotection by adenovirus-mediated Ciliary Neurotrophic factor gene transfer in a rat model of progressive Striatal degeneration. J Neurosci 22:4478\u20134486","journal-title":"J Neurosci"},{"key":"9303_CR23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2004.09.017","volume":"18","author":"K Bantubungi","year":"2005","unstructured":"Bantubungi K, Jacquard C, Greco A et al (2005) Minocycline in phenotypic models of Huntington\u2019s disease. Neurobiol Dis 18:206\u2013217","journal-title":"Neurobiol Dis"},{"key":"9303_CR24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.2042-7158.2010.01124.x","volume":"62","author":"EL Moreira","year":"2010","unstructured":"Moreira EL, Rial D, Duarte FS et al (2010) Central nervous system activity of the proanthocyanidin-rich fraction obtained from croton celtidifolius in rats. J Pharm Pharmacol 62:1061\u20131068","journal-title":"J Pharm Pharmacol"},{"key":"9303_CR25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/toxsci\/kfq036","volume":"115","author":"DS Avila","year":"2010","unstructured":"Avila DS, Colle D, Gubert P et al (2010) A possible neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity. Toxicol Sci 115:194\u2013201","journal-title":"Toxicol Sci"},{"key":"9303_CR26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2990.1999.00212.x","volume":"25","author":"JC Vis","year":"1999","unstructured":"Vis JC, Verbeek MM, De Waal RMW et al (1999) 3- nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum. Neuropathol Appl Neurobiol 25:513\u2013521","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9303_CR27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","volume":"22","author":"DA Shear","year":"1998","unstructured":"Shear DA, Dong J, Gundy CD et al (1998) Comparison of Intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease. Prog Neuro-Psychopharmacol Biol Psychiatry 22:1217\u20131240","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9303_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"9303_CR29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0197-4580(01)00226-3","volume":"22","author":"EH Sharman","year":"2001","unstructured":"Sharman EH, Bondy SC (2001) Effects of age and dietary antioxidants on cerebral electron transport chain activity. Neurobiol Aging 22:629\u2013634","journal-title":"Neurobiol Aging"},{"issue":"10","key":"9303_CR30","volume":"9","author":"LA Ahmed","year":"2014","unstructured":"Ahmed LA, Shehata NI, Abdelkader NF et al (2014) Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice. PLoS One 9(10), e108889","journal-title":"PLoS One"},{"issue":"9","key":"9303_CR31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","volume":"20","author":"TM Woodruff","year":"2006","unstructured":"Woodruff TM, Crane JW, Proctor LM et al (2006) Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J 20(9):1407\u20131417","journal-title":"FASEB J"},{"issue":"9","key":"9303_CR32","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/endo.138.9.5407","volume":"138","author":"E Vega-N\u00fa\u00f1ez","year":"1997","unstructured":"Vega-N\u00fa\u00f1ez E, Alvarez AM, Men\u00e9ndez-Hurtado A et al (1997) Neuronal mitochondrial morphology and transmembrane potential are severely altered by hypothyroidism during rat brain development. Endocrinology 138(9):3771\u20133778","journal-title":"Endocrinology"},{"key":"9303_CR33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0306-4522(00)00020-8","volume":"97","author":"S Ouary","year":"2000","unstructured":"Ouary S, Bizat N, Altairac S et al (2000) Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience 97:521\u2013530","journal-title":"Neuroscience"},{"issue":"9","key":"9303_CR34","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00001756-200006260-00007","volume":"11","author":"DA Shear","year":"2000","unstructured":"Shear DA, Haik KL, Dunbar GL (2000) Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. Neuroreport 11(9):1833\u20131837","journal-title":"Neuroreport"},{"issue":"2","key":"9303_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/exnr.2001.7755","volume":"171","author":"CD Keene","year":"2001","unstructured":"Keene CD, Rodrigues CM, Eich T et al (2001) A bile acid protects against motor and cognitive deficits and reduces Striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. Exp Neurol 171(2):351\u2013360","journal-title":"Exp Neurol"},{"issue":"2","key":"9303_CR36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","volume":"164","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kalonia H, Kumar A (2011) Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164(2):644\u2013654","journal-title":"Br J Pharmacol"},{"issue":"10","key":"9303_CR37","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1073\/pnas.93.10.4765","volume":"93","author":"MJ Forster","year":"1996","unstructured":"Forster MJ, Dubey A, Dawson KM et al (1996) Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci U S A 93(10):4765\u20134769","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9303_CR38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molbrainres.2004.10.033","volume":"133","author":"BS Mandavilli","year":"2005","unstructured":"Mandavilli BS, Boldogh I, Van Houten B (2005) 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Brain Res Mol Brain Res 133(2):215\u2013223","journal-title":"Brain Res Mol Brain Res"},{"key":"9303_CR39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02565.x","volume":"90","author":"EN Maciel","year":"2004","unstructured":"Maciel EN, Kowaltowski AJ, Schwalm FD et al (2004) Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition. J Neurochem 90:1025\u20131035","journal-title":"J Neurochem"},{"issue":"2","key":"9303_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.25004\/IJPSDR.2011.030201","volume":"3","author":"TA Wani","year":"2011","unstructured":"Wani TA, Al-Omara MA, Zargarb S (2011) Huntington disease: current advances in pathogenesis and recent therapeutic strategies. Int J Pharm Sci Drug Res 3(2):69\u201379","journal-title":"Int J Pharm Sci Drug Res"},{"key":"9303_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang H, Ward WF (2006) PGC-1 alpha: a key regulator of energy metabolism. Adv Physiol Educ 30:145\u2013151","journal-title":"Adv Physiol Educ"},{"key":"9303_CR42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F et al (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369","journal-title":"Cell"},{"key":"9303_CR43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE et al (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC 1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4:349\u2013362","journal-title":"Cell Metab"},{"issue":"35","key":"9303_CR44","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.2174\/1381612820666140305224545","volume":"20","author":"A Yadav","year":"2014","unstructured":"Yadav A, Agarwal S, Tiwari SK et al (2014) Mitochondria: prospective targets for neuroprotection in Parkinson's disease. Curr Pharm Des 20(35):5558\u20135573","journal-title":"Curr Pharm Des"},{"key":"9303_CR45","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1093\/brain\/aws254","volume":"135","author":"L T\u00f6nges","year":"2012","unstructured":"T\u00f6nges L, Frank T, Tatenhorst L et al (2012) Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease. Brain 135:3355\u20133370","journal-title":"Brain"},{"key":"9303_CR46","doi-asserted-by":"crossref","unstructured":"Selley ML (2005) Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced striatal dopamine depletion and protein tyrosine nitration in mice. Brain Res 1037:1\u20136","DOI":"10.1016\/j.brainres.2004.02.083"},{"issue":"11","key":"9303_CR47","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","volume":"33","author":"J Bouitbir","year":"2012","unstructured":"Bouitbir J, Charles AL, Echaniz-Laguna A et al (2012) Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a \u2018mitohormesis\u2019 mechanism involving reactive oxygen species and PGC-1. Eur Heart J 33(11):1397\u20131407","journal-title":"Eur Heart J"},{"issue":"1","key":"9303_CR48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1124\/jpet.111.191239","volume":"343","author":"D Impellizzeri","year":"2012","unstructured":"Impellizzeri D, Mazzon E, Paterniti I et al (2012) Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma. J Pharmacol Exp Ther 343(1):21\u201333","journal-title":"J Pharmacol Exp Ther"},{"key":"9303_CR49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0076-6879(00)25449-9","volume":"325","author":"S Narumiya","year":"2000","unstructured":"Narumiya S, Ishizaki T, Uehata M (2000) Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol 325:273\u2013284","journal-title":"Methods Enzymol"},{"key":"9303_CR50","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","volume":"23","author":"A Zacco","year":"2003","unstructured":"Zacco A, Togo J, Spence K et al (2003) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 23:11104\u201311111","journal-title":"J Neurosci"},{"key":"9303_CR51","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","volume":"21","author":"E Colin","year":"2005","unstructured":"Colin E, Regulier E, Perrin V et al (2005) Akt is altered in an animal model of Huntington\u2019s disease and in patients. Eur J Neurosci 21:1478\u20131488","journal-title":"Eur J Neurosci"},{"key":"9303_CR52","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","volume":"2","author":"S Humbert","year":"2002","unstructured":"Humbert S, Bryson EA, Cordelieres FP et al (2002) The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves huntingtin phosphorylation by Akt. Dev Cell 2:831\u2013837","journal-title":"Dev Cell"},{"key":"9303_CR53","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M407528200","volume":"280","author":"H Rangone","year":"2005","unstructured":"Rangone H, Pardo R, Colin E et al (2005) Phosphorylation of arfaptin 2 at Ser260 by Akt inhibits polyQ-huntingtin-induced toxicity by rescuing proteasome impairment. J Biol Chem 280:22021\u201322028","journal-title":"J Biol Chem"},{"issue":"37","key":"9303_CR54","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","volume":"273","author":"U Laufs","year":"1998","unstructured":"Laufs U, Liao JK (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273(37):24266\u201324271","journal-title":"J Biol Chem"},{"key":"9303_CR55","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","volume":"95","author":"M Endres","year":"1998","unstructured":"Endres M, Laufs U, Huang Z et al (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 95:8880\u20138885","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9303_CR56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0076-6879(94)33026-3","volume":"233","author":"JS Beckman","year":"1994","unstructured":"Beckman JS, Chen J, Ischiropoulos H et al (1994) Oxidative chemistry of peroxynitrite. Methods Enzymol 233:229\u2013240","journal-title":"Methods Enzymol"},{"key":"9303_CR57","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.184.4.1425","volume":"184","author":"Y Vodovotz","year":"1996","unstructured":"Vodovotz Y, Lucia MS, Flanders KC et al (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer\u2019s disease. J Exp Med 184:1425\u20131433","journal-title":"J Exp Med"},{"key":"9303_CR58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0166-2236(96)10074-6","volume":"20","author":"C Iadecola","year":"1997","unstructured":"Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132\u2013139","journal-title":"Trends Neurosci"},{"key":"9303_CR59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pnpbp.2015.02.005","volume":"60","author":"DM Hanna","year":"2015","unstructured":"Hanna DM, Tadros MG, Khalifa AE (2015) ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions. Prog Neuropsychopharmacol Biol Psychiatry 60:36\u201351","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9303_CR60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00024382-199712000-00004","volume":"8","author":"BG Harbrecht","year":"1997","unstructured":"Harbrecht BG, Wu B, Watkins SC et al (1997) Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock 8:415\u2013421","journal-title":"Shock"},{"key":"9303_CR61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn1652","volume":"6","author":"T Menge","year":"2005","unstructured":"Menge T, Hartung HP, Stuve O (2005) Statins--a cure-all for the brain? Nat Rev Neurosci 6:325\u2013331","journal-title":"Nat Rev Neurosci"},{"key":"9303_CR62","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1002\/art.23986","volume":"58","author":"Y He","year":"2008","unstructured":"He Y, Xu H, Liang L et al (2008) Antiinflammatory effect of Rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritis. Arthritis Rheum 58:3366\u20133376","journal-title":"Arthritis Rheum"},{"key":"9303_CR63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1523\/JNEUROSCI.2544-04.2005","volume":"25","author":"A Cordle","year":"2005","unstructured":"Cordle A, Landreth G (2005) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate \u03b2-amyloid-induced microglial inflammatory responses. J Neurosci 25:299\u2013307","journal-title":"J Neurosci"},{"issue":"11","key":"9303_CR64","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1074\/jbc.M604298200","volume":"282","author":"DP Re Del","year":"2007","unstructured":"Del Re DP, Miyamoto S, Brown JH (2007) RhoA\/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem 282(11):8069\u20138078","journal-title":"J Biol Chem"},{"key":"9303_CR65","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1248\/bpb.27.961","volume":"27","author":"Y Nomura","year":"2004","unstructured":"Nomura Y (2004) Neuronal apoptosis and protection: effects of nitric oxide and endoplasmic reticulum-related proteins. Biol Pharm Bull 27:961\u2013963","journal-title":"Biol Pharm Bull"},{"key":"9303_CR66","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ncb1747","volume":"10","author":"N Sen","year":"2008","unstructured":"Sen N, Hara MR, Kornberg MD et al (2008) Nitric oxide-induced nuclear GAPDH activates p300\/CBP and mediates apoptosis. Nat Cell Biol 10:866\u2013873","journal-title":"Nat Cell Biol"},{"key":"9303_CR67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45","journal-title":"J Neuroinflammation"},{"issue":"7","key":"9303_CR68","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10571-012-9845-z","volume":"32","author":"J Wu","year":"2012","unstructured":"Wu J, Li J, Hu H et al (2012) Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain. Cell Mol Neurobiol 32(7):1187\u20131197","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"9303_CR69","first-page":"3645","volume":"31","author":"CA Street","year":"2011","unstructured":"Street CA, Bryan BA (2011) Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis. Anticancer Res 31(11):3645\u20133657","journal-title":"Anticancer Res"},{"key":"9303_CR70","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.expneurol.2004.04.004","volume":"188","author":"S Kelly","year":"2004","unstructured":"Kelly S, Zhao H, Hua Sun G et al (2004) Glycogen synthase kinase-3 beta inhibitor Chir025 reduces neuronal death resulting from oxygen\u2013glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol 188:378\u2013386","journal-title":"Exp Neurol"},{"key":"9303_CR71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1874082001004010013","volume":"4","author":"WT Hunt","year":"2010","unstructured":"Hunt WT, Salins PB, Anderson CM et al (2010) Neuroprotective role of statins in Alzheimer\u2019s disease: anti-apoptotic signaling. Open Neurosci J 4:13\u201322","journal-title":"Open Neurosci J"},{"key":"9303_CR72","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2006.10.004","volume":"25","author":"C Franke","year":"2007","unstructured":"Franke C, Noldner M, Abdel-Kader R et al (2007) Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiol Dis 25:438\u2013445","journal-title":"Neurobiol Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9303-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9303-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:52:38Z","timestamp":1748494358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9303-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["9303"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9303-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]}}}